Pharmaceutical composition for treating primary trigeminal neuralgia

Abstract

The invention relates to a pharmaceutical composition for treating primary trigeminal neuralgia. The pharmaceutical composition is prepared from the following raw medicinal materials: scorpio, tortoise shell, semen cassia, rhizoma corydalis, dragon's blood, calculus bovis, fel ursi, adenophora tetraphylla, rhizoma nardostachyos, tendril-leaved fritillary bulb, radix polygonati officinalis, fructus viticis, cinnamon, marsdenia longipes, semen cuscutae and sea horse, wherein the scorpio, tortoise shell and semen cassia are taken as the monarch drug; the rhizoma corydalis, dragon's blood, calculus bovis and fel ursi are taken as the ministerial drug; the adenophora tetraphylla, rhizoma nardostachyos, tendril-leaved fritillary bulb, radix polygonati officinalis are taken as the adjuvant; and the fructus viticis, cinnamon, marsdenia longipes, semen cuscutae and sea horse are taken as the conductant drug. The pharmaceutical composition prescription for treating primary trigeminal neuralgia, disclosed by the invention, is simple in drug flavor, and the various flavors of medicines achieve respective effects, are coordinated with one another, and are compounded together to achieve unexpected technical effects in the aspect of treating the primary trigeminal neuralgia. At present, more than 300 patients of various kinds are cured, and the effective rate can reach 97% or higher. The pharmaceutical composition disclosed by the invention has the advantages of fast efficacy, high efficiency, short course of treatment, difficulty in reoccurrence and the like. In addition, the special four-quadrant preparation process is easy to master and apply.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, relates to a neurology medicine, in particular to a medicine composition for treating primary trigeminal neuralgia. Background technique [0002] Trigeminal neuralgia is a common disease in neurology. It is characterized by recurrent paroxysmal severe pain in the trigeminal nerve distribution area on one side of the face. The symptoms are characterized by sudden onset and sudden arrest in the trigeminal nerve distribution area of ​​the head and face. , Lightning-like, knife-like, burning-like, intractable, unbearable severe pain, which affects normal life and work. According to domestic statistics, the incidence rate of this disease is about 52 cases per 100,000 people. Among them, primary trigeminal neuralgia is the most common type of trigeminal neuralgia. Primary trigeminal neuralgia usually stops suddenly after a few seconds to a few minutes without other complications. ...

AI Technical Summary

Problems solved by technology

There are particularly sensitive trigger points in the distribution area of ​​the trigeminal nerve, and the pain is often limited to one or more branches of the unilateral trigeminal nerve. In recent years, thanks to the development of microvascular decompression in neurosurgery, the primary Trigeminal neuralgia is also closely related to facial microvascular, the main reason is that adjacent blood vessels compress the trigeminal nerve root, most of them are small glue arteries compressing the nerve root from the upper or inner upper part of the trigeminal nerve root, a few Because the anterior inferior cerebellar artery compresses the nerve root from below the root of the trigeminal nerve, as a response, the more commonly used methods in clinical practice focus on neurosurgery, peripheral branch avulsion, amputation, and trigeminal nerve tractectomy It is suitable for patients of all ages, and it is relatively painful, high-risk, and expensive; in the field of neurology, most of them can only passively control and alleviate the disease by taking carbamazepine or alcohol injection, but the treatment effect is poor , long recovery period, and easy recurrence. Carbamazepine, the first choice drug for trigeminal neuralgia, is difficult to be used for a long time due to its large side effects or high risk